Implication of CD35, CD21 and CD55 in Exudative Age-related Macular Degeneration

• Conditions: Age-Related Macular Degeneration
• Interventions: Other: cd 35, cd21, cd55

• Registration Number: NCT01174407
• Lead Sponsor: Rudolf Foundation Clinic

Brief Summary

The purpose of this study is to determine a possible implication of CD21, CD35 and CD55 in the pathogenesis of age-related macular degeneration. The aim is to asses a difference in expression rates of these factors on AMD-patients and a healthy control group.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-09
• Study First Submitted: 2008-11-19
• Primary Completion: 2009-12
• Status Verified: 2010-08
• Study Completion: 2010-08
• Study First Submitted QC: 2010-08-02
• Last Update Submitted: 2010-08-02
• Study First Posted: 2010-08-03
• Last Update Posted: 2010-08-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

• Man and women over 18 years old
• Filled out informed consent
• Diagnosis of non-exudative/ exudative age related macular degeneneration

Exclusion Criteria

• Inherited retinal diseases
• Other acquired retinal/ macular
• Missing informed consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
cd35	cd 35, cd21, cd55	-

Primary Outcome Measures

Name	Time	Method
determine a possible implication of CD21, CD35 and CD55 in the pathogenesis of age-related macular degeneration	1 day

Secondary Outcome Measures

Name	Time	Method
expression rates of on AMD-patients and a healthy control group	1 year

Trial Locations

Locations (1)

Rudolf Foundation Clinic; 🇦🇹 Vienna, Austria